HAS2 controls HA synthesis in HSCs, and HAS2-derived HA promotes fibrosis progression and cancer aggressiveness in breast, esophageal, bile duct, pancreatic, and other cancers (17, 18, 20, 36–38). This evidence concerns the gene HAS2 and cancer.